BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26443113)

  • 1. [Unusual causes of hyperprolactinaemia].
    de Haar-Holleman A; Musson RE; Eelkman Rooda SJ; Wielders JP; Demir AY
    Ned Tijdschr Geneeskd; 2015; 159():A9051. PubMed ID: 26443113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with macroprolactinaemia: clinical and radiological features.
    Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
    Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for macroprolactinaemia and pituitary imaging studies.
    Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acromegaly masked by symptomatic hyperprolactinaemia].
    Dal J; Steffensen C; Hansen TK; Jørgensen JO
    Ugeskr Laeger; 2014 Jan; 176(1):60-1. PubMed ID: 24629611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and radiological features of patients with macroprolactinaemia.
    Strachan MW; Teoh WL; Don-Wauchope AC; Seth J; Stoddart M; Beckett GJ
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):339-46. PubMed ID: 12919157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas.
    Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A
    Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of macroprolactin by precipitation and ultrafiltration methods.
    Beda-Maluga K; Pisarek H; Komorowski J; Pawlikowski M; Świętosławski J; Winczyk K
    Endokrynol Pol; 2011; 62(6):529-36. PubMed ID: 22144220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macroprolactin-a cause of pseudohyperprolactinaemia.
    Yuen YP; Lai JP; Au KM; Chan AY; Mak TW
    Hong Kong Med J; 2003 Apr; 9(2):119-21. PubMed ID: 12668823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference by macroprolactin in assays for prolactin: will the
    Fahie-Wilson MN; Cobbaert CM; Horvath AR; Smith TP
    Clin Chem Lab Med; 2022 Aug; 60(9):1350-1355. PubMed ID: 35704648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroprolactin screening in 464 patients with hyperprolactinaemia.
    Lim MH; Ho CKM
    Malays J Pathol; 2022 Aug; 44(2):261-267. PubMed ID: 36043589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol.
    Fahie-Wilson MN; Soule SG
    Ann Clin Biochem; 1997 May; 34 ( Pt 3)():252-8. PubMed ID: 9158821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three cases of macroprolactinaemia.
    Olukoga AO; Dornan TL; Kane JW
    J R Soc Med; 1999 Jul; 92(7):342-4. PubMed ID: 10615271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macroprolactinaemia, the major unknown in the differential diagnosis of hyperprolactinaemia.
    Cattaneo F; Kappeler D; Müller B
    Swiss Med Wkly; 2001 Mar; 131(9-10):122-6. PubMed ID: 11416967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Macroprolactinaemia].
    Kostrzak A; Meczekalski B
    Pol Merkur Lekarski; 2010 Jul; 29(169):47-9. PubMed ID: 20712249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hyperprolactinaemia in female premenopausal blood donors.
    Alpañés M; Sanchón R; Martínez-García MÁ; Martínez-Bermejo E; Escobar-Morreale HF
    Clin Endocrinol (Oxf); 2013 Oct; 79(4):545-9. PubMed ID: 23445257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary hypothyroidism with hyperprolactinaemia and pituitary enlargement mimicking a pituitary macroadenoma.
    Ozbey N; Sariyildiz E; Yilmaz L; Orhan Y; Sencer E; Molvalilar S
    Int J Clin Pract; 1997 Sep; 51(6):409-11. PubMed ID: 9489077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation.
    Beda-Maluga K; Pisarek H; Komorowski J; Swietoslawski J; Fuss-Chmielewska J; Winczyk K
    J Physiol Pharmacol; 2014 Jun; 65(3):359-64. PubMed ID: 24930507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia.
    Le Moli R; Endert E; Fliers E; Prummel MF; Wiersinga WM
    Neth J Med; 2003 Feb; 61(2):44-8. PubMed ID: 12735420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
    Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperprolactinaemia; when is a prolactinoma not a prolactinoma?
    Lancet; 1987 Oct; 2(8566):1002-4. PubMed ID: 2889909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.